Medicare Enrolled
Dr. Anne Housholder, MD
Student in an Organized Health Care Education/Training Program · Cincinnati, OH
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Housholder from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Housholder?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Housholder
Dr. Anne Housholder is a student in an organized health care education/training program specialist in Cincinnati, OH, with 17 years of NPI registration. Based on federal Medicare data, Dr. Housholder performed 2,160 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Housholder received a total of $2,831 from 27 pharmaceutical and/or device companies across 118 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Housholder is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years of NPI registration
▲ Top 4% volume in OH
$2,831 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,160
Medicare services
Top 4% in OH for student in an organized health care education/training program
Not available
Unique patients (not deduplicated)
$38
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
690 | $5 | $30 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
316 | $61 | $120 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
229 | $35 | $118 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
204 | $37 | $65 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
185 | $71 | $143 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
122 | $1 | $7 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
109 | $72 | $150 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
86 | $44 | $110 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
51 | $63 | $154 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
47 | $91 | $140 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
19 | $39 | $75 |
| Destruction of cancer skin growth, 1.1-2.0 cm Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters. |
19 | $92 | $305 |
| Destruction of cancerous skin growth on face, 0.6-1.0 cm This procedure involves the removal or destruction of a cancerous skin lesion located on the face, ears, eyelids, nose, lips, or mouth. The lesion treated measures between 0.6 and 1.0 centimeters in diameter. |
19 | $110 | $355 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
15 | $115 | $225 |
| Destruction of cancer skin growth, 0.6-1.0 cm This procedure involves the removal or destruction of a cancerous skin growth located on the trunk, arms, or legs that measures between 0.6 and 1.0 centimeters. |
13 | $88 | $235 |
| Skin tag removal, 1-15 tags This procedure involves the removal of one to fifteen skin tags. It is a minor surgical intervention to excise these benign growths from the skin. |
12 | $50 | $121 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
12 | $120 | $520 |
| Destruction of cancerous skin growth on face, 1.1-2.0 cm This procedure involves the removal or destruction of a cancerous skin lesion located on the face, ears, eyelids, nose, lips, or mouth. The lesion treated measures between 1.1 and 2.0 centimeters in diameter. |
12 | $115 | $450 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$2,831
Total received (2018-2024)
Avg $404/year across 7 years
Top 10% in OH for student in an organized health care education/training program
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
27
Companies
118
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,068
2023
$1,039
2022
$394
2021
$55
2020
$34
2019
$127
2018
$114
Payments by company (2024)
ABBVIE INC.
$319
E.R. Squibb & Sons, L.L.C.
$293
Lilly USA, LLC
$66
Novartis Pharmaceuticals Corporation
$61
Regeneron Healthcare Solutions, Inc.
$46
LEO Pharma Inc.
$43
Amgen Inc.
$42
Arcutis Biotherapeutics, Inc.
$39
GENZYME CORPORATION
$38
UCB, Inc.
$28
Biocon Biologics Inc
$22
Janssen Biotech, Inc.
$17
Alnylam Pharmaceuticals Inc.
$16
Dermavant Sciences, Inc.
$14
Galderma Laboratories, L.P.
$13
Organon Llc
$10
Top 3 companies account for 63.5% of 2024 payments
All-time payments by company (2018-2024) ›
E.R. Squibb & Sons, L.L.C.
$448
ABBVIE INC.
$391
Amgen Inc.
$310
UCB, Inc.
$192
Regeneron Healthcare Solutions, Inc.
$188
Janssen Biotech, Inc.
$162
Lilly USA, LLC
$151
Novartis Pharmaceuticals Corporation
$138
Paratek Pharmaceuticals, Inc.
$125
LEO Pharma Inc.
$103
Dermavant Sciences, Inc.
$94
GENZYME CORPORATION
$90
Ortho Dermatologics, a division of Bausch Health US, LLC
$77
SANOFI-AVENTIS U.S. LLC
$60
Kyowa Kirin, Inc.
$42
Fresenius Kabi USA, LLC
$41
Sandoz Inc.
$40
Arcutis Biotherapeutics, Inc.
$39
Biocon Biologics Inc
$22
Boehringer Ingelheim Pharmaceuticals, Inc.
$21
Almirall LLC
$19
Alnylam Pharmaceuticals Inc.
$16
PFIZER INC.
$15
Sun Pharmaceutical Industries Inc.
$14
Galderma Laboratories, L.P.
$13
Genentech USA, Inc.
$11
Organon Llc
$10
Top 3 companies account for 40.5% of all-time payments
Associated products mentioned in payments ›
ADBRY · APEXICON E · Bimzelx · COSENTYX · Cimzia · DUPIXENT · EUCRISA · Erivedge · GIVLAARI · HADLIMA · Hulio · IDACIO · LIBTAYO · NUZYRA · Otezla · POTELIGEO · Poteligeo · REMICADE · RINVOQ · SKYRIZI · SPEVIGO · Seysara · Sotyktu · TALTZ · TREMFYA · VTAMA · Winlevi · Zoryve
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Student in an organized health care education/training programs in nearby ZIP areas
2,645
County median income
$70,816
Nearest hospital to ZIP centroid (approximate)
BLUERIDGE VISTA HEALTH AND WELLNESS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Housholder is a clinical cardiology specialist, with above-average Medicare volume (top 4% in OH), with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Housholder experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Housholder performed 690 destruction of precancerous skin growths, 2-14 services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Housholder receive payments from pharmaceutical companies?
Yes. Dr. Housholder received a total of $2,831 from 27 companies across 118 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Housholder's costs compare to other student in an organized health care education/training programs in Cincinnati?
Dr. Housholder's average Medicare payment per service is $38. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Housholder) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Student In An Organized Health Care Education/training Programs in Cincinnati
Browse student in an organized health care education/training programs in Cincinnati ranked by procedure volume and transparency data.
Highest volume
Top Student In An Organized Health Care Education/training Programs in OH
Student in an organized health care education/training programs ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Student In An Organized Health Care Education/training Programs in OH
Which OH student in an organized health care education/training programs receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology